Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | DHODH | Q02127 | 3/20 | 0.47 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.47 |
| ▸ | TNF | P01375 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19986171 | 0.97 | DHODH (0.51) | ALDH1A1MAPTKDM4EMEN1LMNA | |
| SCHEMBL19986172 | 0.91 | DHODH (0.46) | ALDH1A1MAPTKDM4EMEN1LMNA | |
| SCHEMBL1104820 | 0.83 | CYP1A2 (0.62) | ALDH1A1MAPTKDM4ENPSR1HPGD | |
| Iodide SCHEMBL30847747 | 0.81 | CYP1A2 (0.60) | ALDH1A1MAPTKDM4ENPSR1HPGD | |
| SCHEMBL28389108 | 0.81 | MAPK1 (0.49) | ALDH1A1MAPTKDM4EMEN1LMNA | |
| SCHEMBL18731749 | 0.80 | CYP1A2 (0.58) | ALDH1A1MAPTKDM4ENPSR1HPGD | |
| SCHEMBL28046901 | 0.77 | PSMB5 (0.51) | ALDH1A1MAPTKDM4EMEN1LMNA | |
| SCHEMBL18266942 | 0.75 | CYP1A2 (0.57) | KDM4EKDM4CCYP1A2TDP1POLB | |
| SCHEMBL17691562 | 0.75 | KDM4E (0.50) | ALDH1A1MAPTKDM4EMEN1LMNA | |
| SCHEMBL17932284 | 0.75 | CYP1A2 (0.53) | ALDH1A1MAPTKDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10032999-B2 | Compound for organic optoelectric device, composition for organic optoelectric device and organic optoelectric device and display device | SAMSUNG SDI CO., LTD. (KR) | 2018-07-24 | — | — | US | disclosed |
| US-20180090690-A1 | COMPOUND FOR ORGANIC OPTOELECTRIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
| US-20180083202-A1 | COMPOUND FOR ORGANIC OPTOELECTRIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10032999-B2 | Compound for organic optoelectric device, composition for organic optoelectric device and organic optoelectric device and display device | OXER1, OCIAD1, OR10J3 | ALDH1A1 57/4885MAPT 2219/4885KDM4E 3867/4885 |
| US-20180090690-A1 | COMPOUND FOR ORGANIC OPTOELECTRIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | OXER1, OCIAD1, OR10J3 | ALDH1A1 57/4885MAPT 2219/4885KDM4E 3867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.